Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986;6(2):79-83.
doi: 10.1007/BF00541509.

Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes

Comparative Study

Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes

J S Coppock et al. Rheumatol Int. 1986.

Abstract

Fibronectin is involved in the opsonic clearance of particulate material. It is present in plasma and synovial fluid and thus might be expected to have a role in the clearance of immune complexes. We have investigated this in a study of polyethylene glycol (PEG) precipitable material from the serum of patients with rheumatoid arthritis, systemic lupus erythematosus, and other connective tissue disorders. Fibronectin is a significant component of PEG precipitates but the amount present is influenced by the method of preparation: more precipitates at 4 degrees C than at 20 degrees C. Fibronectin precipitation by PEG was considered to be related to immune complexes because: there was no direct relationship between serum fibronectin levels and the amount present in PEG precipitates; radiolabelled purified isolated fibronectin did not precipitate in 4% PEG; there was a direct relationship between the amount of fibronectin in PEG precipitates and the amounts of immunoglobulin G, A, and M. These results indicate that fibronectin is involved in immune complexes in rheumatic diseases, though they do not show it has an important biological role in these circumstances.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1984 Jun 1;159(6):1618-28 - PubMed
    1. FEBS Lett. 1981 Jun 29;129(1):188-92 - PubMed
    1. Clin Exp Immunol. 1983 Jul;53(1):233-8 - PubMed
    1. Lab Invest. 1979 Mar;40(3):350-7 - PubMed
    1. J Exp Med. 1983 Jun 1;157(6):1844-54 - PubMed

Publication types

MeSH terms